Discover
Deep Margin
31 Episodes
Reverse
In this episode we're delighted to welcome Professor Barbara Burtness from Yale School of Medicine to discuss the exciting results of the OrigAMI-4 trial and what they could mean for the future of head and neck cancer treatment.We explore the emerging role of amivantamab. Barbara takes us through the rationale behind the study, its encouraging clinical results, and the potential implications for patients who have progressed despite immunotherapy and chemotherapy.
We're honoured to welcome back great friend of the show Kevin Harrington who talks us through the ASCO data, his own hobby horses and gives food for thought for ESMO! Will asks more great questions and Ben is there too.
Andrew Schache joins us - our first New Zealander but out second from the Liverpool head and neck unit. Drawing on his extensive experience, Professor Schache also reflects on the evolution of reconstructive surgery, key developments within the field, and the importance of research, education and innovation in improving patient care. Whether you are a medical student, trainee, surgeon, academic or simply interested in how surgical practice continues to develop, this episode offers an engaging and accessible insight into the past, present and future of reconstruction in surgery.
Lockie MacDowell from Princess Alexandra Hospital in Brisbane and the 'Red Journal' talks to us about PROs and his work in helping generate really important evidence around survivorship. We talk sex, side effects, symptoms, communication and mobilising internal resources - something for everyone!
Prof Evans joins us live from sunny Wales to give us the lowdown on TNM 9 and where it sits. This will give Ben and Will something to talk about at parties.








